Advanced Heart Failure Market Set for Robust Growth Through 2032, Driven by Emerging Therapeutic Pipeline and Rising Disease Awareness | DelveInsight

The advanced heart failure market is experiencing significant expansion, driven by increasing disease awareness, rising prevalence, and breakthrough therapies from key pharmaceutical companies such as Bayer, Abbott, Boehringer Ingelheim, Novartis, AstraZeneca, Merck, Bristol Myers Squibb, Pfizer, and Johnson & Johnson